Akums Drugs and Pharmaceuticals’ shares began trading at Rs 725, a 6.8% premium over the issue price of Rs 679, after an IPO that was subscribed 63.5 times. The company will use the IPO proceeds for debt repayment, working capital, and acquisitions. Revenue grew 14% in FY24, while profits saw a decline.
Honasa Consumer shares jump 7% as Q2 operating update points to strong growth
Honasa Consumer shares rallied after the company projected strong Q2 FY27 operating performance, with net sales growth expected in the early thirties, improving margins and